Update on the treatment of disseminated fusariosis: Focus on voriconazole

References

• Al-AbdelyHMManagement of rare fungal infectionsCurr Opin Infect Dis2004175273215640706
   PubMed Web of Science ®Google Scholar
• AlkanYHaefeliWEBurhenneJVoriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effectClin Infect Dis200439e495215472801
   PubMed Web of Science ®Google Scholar
• Alvarez-LermaFNicolas-ArfelisJMRodriguez-BorreganJCClinical use and tolerability of voriconazole in the treatment of fungal infections in critically ill patientsJ Chemother2005174172716167522
   PubMed Web of Science ®Google Scholar
• AnaissieEKantarjianHJonesPFusarium. A newly recognized fungal pathogen in immunosuppressed patientsCancer198657214153457624
   PubMed Web of Science ®Google Scholar
• AnandiVVishwanathanPSasikalaSFusarium solani breast abscessIndian J Med Microbiology2005231989
   Google Scholar
• ApostolidisJBouzaniMPlatsoukaEResolution of fungemia due to Fusarium spp. in a patient with acute leukemia treated with caspofunginClin Infect Dis20033613495012746788
   PubMed Web of Science ®Google Scholar
• ArikanSLozano-ChiuMPaetznickVMicrodilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium speciesJ Clin Microbiol19993739465110565912
   PubMed Web of Science ®Google Scholar
• AustenBMcCarthyHWilkinsBFatal disseminated Fusarium infection in acute lymphoblastic leukemia in complete remissionJ Clin Pathol2001544889011376027
   PubMed Web of Science ®Google Scholar
• BigleyVHDuarteRFGoslingRDFusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazoleBone Marrow Transplant2004348151715361915
   PubMed Web of Science ®Google Scholar
• BodeyGPBoktourMMaysSSkin lesions associated with Fusarium infectionJ Am Acad Dermatol2002476596612399756
   PubMed Web of Science ®Google Scholar
• BoutatiEAnaissieEJFusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years’ experience at a cancer center and implications for managementBlood19979099910089242529
   PubMed Web of Science ®Google Scholar
• BunyaVYHammersmithKMRapuanoCJTopical and oral voriconazole in the treatment of fungal keratitisAm J Ophthalmol2007143151317188052
   PubMed Web of Science ®Google Scholar
• CharvalosETsatsakisATzatzarakisMNew nystatin polymeric complexes and their in vitro antifungal evaluation in a model study with Fusarium oxysporumMycopathologia2002153151911913760
   PubMed Web of Science ®Google Scholar
• CocurocciaBGaidoJGubinelliELocalized cutaneous hyalohyphomycosis caused by Fusarium spp. infection in a renal transplant patientJ Clin Microbiology2003419057
   PubMed Web of Science ®Google Scholar
• ConsignySDhedinNDatryASuccessful voriconazole treatment of disseminated Fusarium infection in an immunocompromised patientClin Infect Dis2003373111312856225
   PubMed Web of Science ®Google Scholar
• CudilloLGirmeniaCSantilliSBrekthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxisClin Infect Dis20054012121315791530
   PubMed Web of Science ®Google Scholar
• Cuenca-EstrellaMGomez-LopezAMelladoEHead-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungiAntimicrob Agents Chemother2006509172116495251
   PubMed Web of Science ®Google Scholar
• DenningDWRibaudPMilpiedNEfficacy and safety of voriconazole in the treatment of acute invasive aspergillosisClin Infect Dis2002345637111807679
   PubMed Web of Science ®Google Scholar
• DenningDWKibblerCCBarnesRABritish Society for Medical Mycology proposed standards of care for patients with invasive fungal infectionsLancet Infect Dis200332304012679266
   PubMed Web of Science ®Google Scholar
• DismukesWEIntroduction to antifungal drugsClin Infect Dis200030653710770726
   PubMed Web of Science ®Google Scholar
• DurandMLKimIKD’AmicoDJSuccessful treatment of Fusarium endophtalmitis with voriconazole and Aspergillus endophtalmitis with voriconazole plus caspofunginAm J Ophtalmology20051405524
   PubMed Web of Science ®Google Scholar
• Espinel-IngroffAComparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeastsJ Clin Microbiol199836295069738049
   PubMed Web of Science ®Google Scholar
• Espinel-IngroffAFothergillAGhannoumMQuality control and reference guidelines for CLSI broth microdilution susceptibility method (M38-A Document) for amphotericin B, itraconazole, posaconazole and voriconazoleJ Clini Microbiol20054352436
   PubMed Web of Science ®Google Scholar
• European Agency for the Evaluation of Medical ProductsVFEND: summary of product characteristics [online]2007 URL: http://www.emea.eu.int.
   Google Scholar
• GarbinoJUckayIRohnerPFusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literatureTranspl Int2005186131815819812
   PubMed Web of Science ®Google Scholar
• GhannoumMAKuhnDMVoriconazole – better chances for patients with invasive mycosesEur J Med Res200272425612069915
   PubMed Web of Science ®Google Scholar
• GiaconiJAMarangonFBMillerDVoriconazole and fungal keratitis: a report of two treatment failuresJ Ocul Pharmacol Ther200622437917238810
   PubMed Web of Science ®Google Scholar
• GormanSRMagiorakosAPZimmermanSKFusarium oxysporum pneumonia in an immunocompetent hostSouth Med J2006996131616800418
   PubMed Web of Science ®Google Scholar
• GuarroJGeneJOpportunistic fusarial infections in humansEur J Clin Microbiol Infect Dis199514741548536721
   PubMed Web of Science ®Google Scholar
• Guimerá-Martí-NedaFGarcía-BustínduyMNoda-CabreraACutaneous infection by Fusarium: successful treatment with oral voriconazoleBritish J Dermatol200415077095
   Web of Science ®Google Scholar
• Guzman-CottrillJAXiaotianZhengChadwickEGFusarium solani endocarditis successfully treated with liposomial amphotericin B and voriconazolePediatric Infect Dis J200423105960
   PubMed Web of Science ®Google Scholar
• HamakiTKamiMKishiAVesicles as initial skin manifestation of disseminated fusariosis after non-myeloablative stem cell transplantationLeuk Lymphoma200445631315160931
   PubMed Web of Science ®Google Scholar
• HerbrechtRDenningDWPattersonTFVoriconazole versus amphotericin B for primary therapy of invasive aspergillosisN Engl J Med20023474081512167683
   PubMed Web of Science ®Google Scholar
• HerbrechtRVoriconazole: therapeutic review of a new azole antifungalExpert Rev Anti Infect Ther200424859715482215
   PubMedGoogle Scholar
• HerbrechtRKesslerRKravanjaCSuccessful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipientJ Heart Lung Transplant2004231451415607679
   PubMed Web of Science ®Google Scholar
• HeynKTredupASalvenmoserSEffect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp and Fusarium solaniJ Antimicrob Chemother20054951579
   Web of Science ®Google Scholar
• HsuCKHsuMMLeeJYFusariosis occurring in an ulcerated cutaneous CD8+ T cell lymphoma tumorEur J Dermatol20061629730116709499
   PubMed Web of Science ®Google Scholar
• JensenTGGahrn-HansenBArendrupMFusarium fungemia in immunocompromised patientsClin Microbiol Infect20041049950115191376
   PubMed Web of Science ®Google Scholar
• JohnsonEMSzekelyAWarnockDWIn-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungiJ Antimicrob Chemother199842741510052897
   PubMed Web of Science ®Google Scholar
• JohnsonLBKauffmanCAVoriconazole: a new triazole antifungal agentClin Infect Dis200336630712594645
   PubMed Web of Science ®Google Scholar
• KhouryHBallNJDisseminated fusariosis in a patient with acute leukemiaBr J Haematol2003120112492568
   PubMed Web of Science ®Google Scholar
• KivivouriSMHoviLVetternantaKInvasive fusariosis in two transplanted childrenEur J Pediatr2004163692315322867
   PubMed Web of Science ®Google Scholar
• KontoyiannisDPBodeyGPHannaHOutcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recoveryLeuk Lymphoma2004451394115061210
   PubMed Web of Science ®Google Scholar
• KrcmeryVJrJesenskaZSpanikSFungaemia due to Fusarium spp. in cancer patientsJ Hosp Infect19973622389253703
   PubMed Web of Science ®Google Scholar
• LewisRWiederholdNPKlepserMEIn vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillusm, Fusarium and Scedosporium sppAntimicrob Agents Chemother2005499455115728887
   PubMed Web of Science ®Google Scholar
• LinHCChuPHKuoYHClinical experience in managing Fusarium solani keratitisInt Clin Pract20055954954
   PubMed Web of Science ®Google Scholar
• LinaresMJCharrielGSolÍFSusceptibility of filamentous fungi to voriconazole tested by two microdilution methodsJ ClinMicrobiol2005432503
   Google Scholar
• LindenPWilliamsPChanKMEfficacy and safety of amphotericine B lipid complex injection (ABLC) in solid organ transplant recipients with invasive fungal infectionClin Transpl20001432939
   PubMed Web of Science ®Google Scholar
• LodatoFTaméMRMontagnaniMSystemic fungemia and hepatic localization of Fusarium solani in a liver transplanted patient: an emerging fungal agentLiver Transpl20061217111417058254
   PubMed Web of Science ®Google Scholar
• MadariagaMGKohlSDisseminated fusariosis presenting with pulmonary nodules following a line infectionBraz J Infect Diseases200610426
   Google Scholar
• MarcoFPfallerMAMesserSAAntifungal activity of a new triazole, voriconazole (UK-109, 496), compared with three other antifungal agents tested against clinical isolates of filamentous fungiMed Mycol199836433610206756
   PubMed Web of Science ®Google Scholar
• MarrKACarterRACrippaFEpidemiology and outcome of mould infections in hematopoietic stem cell transplant recipientsClin Infect Dis2002349091711880955
   PubMed Web of Science ®Google Scholar
• MouasHLutsarIDupontBVoriconazole for invasive bone aspergillosis: a worldwide experience of 20 casesClin Infect Dis20054011414715791514
   PubMed Web of Science ®Google Scholar
• MusaMOAl EisaAHalimMThe spectrum of Fusarium infection in immunocompromised patients with hematological malignancies and in non-immunocompromised patients: a single institution experience over 10 yearsBr J Haematol2000108544810759712
   PubMed Web of Science ®Google Scholar
• NelsonPEDignaniMCAnaissieEJTaxonomy, biology, and clinical aspects of Fusarium speciesClin Microbiol Rev199474795047834602
   PubMed Web of Science ®Google Scholar
• NucciMAnaissieEJCutaneous infection by Fusarium species in healthy and immunocompromised host: implication for diagnosis and managementClin Infect Dis2002359092012355377
   PubMed Web of Science ®Google Scholar
• NucciMEmerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipientsCurr Opin Infect Dis2003166071214624113
   PubMed Web of Science ®Google Scholar
• NucciMAnaissieEJQueiroz-TellesFOutcome predictors of 84 patients with hematologic malignancies and Fusarium infectionCancer2003983151912872351
   PubMed Web of Science ®Google Scholar
• NucciMMarrKAQueiroz-TellesFFusarium infection in hematopoietic stem cell transplant recipientsClin Infect Dis20043812374215127334
   PubMed Web of Science ®Google Scholar
• OliveiraJSKerbauyFRColomboALFungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazoleBraz J Med Biol Res2002357899812131918
   PubMed Web of Science ®Google Scholar
• PaphitouNIOstrosky-ZeichnerLPaetznickVLIn vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test resultsAntimicrob Agents Chemother200246329830012234865
   PubMed Web of Science ®Google Scholar
• PereiroMJrAbaldeMTZulaicaAChronic infection due to Fusarium oxysporum mimicking lupus vulgaris: case report and review of cutaneous involvement in fusariosisActa Derm Venereol20018151311411917
   PubMed Web of Science ®Google Scholar
• PerfectJRMarrKAWalshTJVoriconazole treatment for less-common, emerging, or refractory fungal infectionsClin Infect Dis20033611223112715306
   PubMed Web of Science ®Google Scholar
• PfallerMAMarcoFMesserSAIn vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743, 792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungiDiagn Microbiol Infect Dis19983025159582584
   PubMed Web of Science ®Google Scholar
• PfallerMAMesserSAMillsKIn vitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICsJ Clin Microbiol20003833596110970383
   PubMed Web of Science ®Google Scholar
• PfallerMAMesserSAHollisRJAntifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000Antimicrob Agents Chemother2002461032711897586
   PubMed Web of Science ®Google Scholar
• PhilipAOdabasiZRodriguezJIn vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp and Fusarium sppAntimicrob Agents Chemother2005493572416048988
   PubMed Web of Science ®Google Scholar
• PolizziASiniscalchiCMastromarinoAEffect of voriconazole on a corneal abscess caused by FusariumActa Ophtalmol Scand2004827624
   Google Scholar
• PotoskiBABrownJThe safety of voriconazoleClin Infect Dis2002345637111807679
   PubMed Web of Science ®Google Scholar
• RaadIHachemRYHerbrechtRPosaconazole as salvage treatment for invasive fusariosis in patients with underlying hematological malignancies and other conditionsClin Infect Dis200642139840316619151
   PubMed Web of Science ®Google Scholar
• ReisASundmacherRTintelnotKSuccessful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazoleBr J Ophthalmol2000849323310979655
   PubMed Web of Science ®Google Scholar
• RodriguezCALuján-ZilbermannJWooderdPSuccessful treatment of disseminated fusariosisBone Marrow Transpl20033141112
   PubMed Web of Science ®Google Scholar
• SagnelliCFumagalliLPrigitanoASuccessful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapyJ Antimicrob Chemother200657796816469850
   PubMed Web of Science ®Google Scholar
• SampathkumarPPayaCVFusarium infection after solid organ transplantClin Infect Dis20013212374011283817
   PubMed Web of Science ®Google Scholar
• ScottLJSimpsonDVoriconazole: a review of its use in the management of invasive fungal infectionsDrugs2007672699817284090
   PubMed Web of Science ®Google Scholar
• SelleslagDA case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin BActa Biomed200677Suppl 232516918066
   PubMedGoogle Scholar
• SinghNImpact of current transplantation practices on the changing epidemiology of infections in transplant recipientsLancet Infect Dis200331566112614732
   PubMed Web of Science ®Google Scholar
• SpellbergBSchwartzJFuYComparison of antifungal treatments for murine fusariosisJ Antimicrob Chemother200658973916973654
   PubMed Web of Science ®Google Scholar
• SponselWEGraybillJRNevarezHLOcular and systemic posaconazole (SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitisBr J Ophthalmol2002868293012084760
   PubMed Web of Science ®Google Scholar
• StanzaniMVianelliNBandiniGSuccessful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomial amphotericinB J Infect200653e2436
   Web of Science ®Google Scholar
• TeixeiraABSilvaMLyraLAntifungal susceptibility and pathogenic potential of environmental isolated filamentous fungi compared with colonizing agents in immunocompromised patientsMycopathologia20051601293516170608
   PubMed Web of Science ®Google Scholar
• TorresHAHachemRYChemalyRFPosaconazole: a broad-spectrum tiazole antifungalLancet Infect Dis200557758516310149
   PubMed Web of Science ®Google Scholar
• TuEYMcCartneyDLBeattyRFSuccessful treatment of resistant ocular fusariosis with posaconazole (SCH-56592)Am J Ophtalmol20071432227
   PubMed Web of Science ®Google Scholar
• VincentALCabreroJEGreeneJNSuccessful voriconazole therapy of disseminated Fusarium solani in the brain of a neutropenic cancer patientCancer Control2003104141914581897
   PubMedGoogle Scholar
• WalshTJGrollAHiemenzJInfections due to emerging and uncommon medically important fungal pathogensClin Microbiol Infect200410Suppl 1486614748802
   PubMed Web of Science ®Google Scholar
• YoungCNMeyersAMOpportunistic fungal infection by Fusarium oxysporum in a renal transplant patientSabouraudia19791721923394364
   PubMedGoogle Scholar